July 11, 2014 6:50 AM ET

Biotechnology

Company Overview of Chroma Therapeutics Ltd.

Executive Profile

Paul Workman Ph.D.

Founder,Chairman of Scientific Advisory Board and Director, Chroma Therapeutics Ltd.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 5 different industries.

See Board Relationships
----

Background

Dr. Paul Workman, PhD, DSc (Hon), FMedSci, FSB, FRSC, is the Founder, Chairman of Scientific Advisory Board and Director at Chroma Therapeutics Ltd. Dr. Workman serves as the Deputy Chief Executive of the Institute of Cancer Research (ICR). He is also Head of the Division of Cancer Therapeutics at ICR, Director of the Cancer Research UK Cancer Therapeutics Unit. He is a Harrap Professor of Pharmacology and Therapeutics at The Institute of Cancer Research. He has been ...

Corporate Headquarters

93 Milton Park
Abingdon, Oxfordshire OX14 4RY

United Kingdom

Phone: 44 1235 829120
Fax: 44 1235 829125

Board Members Memberships

Founder,Chairman of Scientific Advisory Board and Director

Education

PhD
University of Leeds

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Chroma Therapeutics Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.